The Ghanaian Federation of Traditional Medicine Practitioners (GHAFTRAM) and the Food and Drugs Authority (FDA) hosted a one-day workshop for producers and manufacturers of herbal medicines on the need to protect human health and consumer safety.
Addressing attendees, Mr. John Odai-Tettey, central regional director of the FDA, said the use of herbal / herbal medicines is on the rise around the world and continues to expand.
“The National Regulatory Authority, like the FDA in Ghana, therefore has a duty to ensure that herbal medicines are manufactured to meet quality standards, are safe and effective,” he said.
To achieve this, he said manufacturers must use the current code of good manufacturing practices (GMP) to ensure that every step of the manufacturing process meets a predetermined standard.
In addition, he noted, the products, their safety and efficacy must be incorporated into manufacturing processes for the public good and expressed concern that the majority of herbal medicine manufacturers do not not taken measures to regularize their operations.
The FDA, as part of its regulatory activities to protect the health and safety of consumers, has provided industrial / technical support services to increase the knowledge base of manufacturers.
Participants were guided through the GMP requirements for the manufacture, packaging, labeling and dosing of herbal medicines.
Working in small groups, participants had hands-on experience in relevant areas of documentation and were assured of the necessary assistance to enable them to register their products.
GHAFTRAM and the FDA have worked together over the years to improve the production of medicinal plants.
Mr. Abubakari Acquah, GHAFTRAM Chairman of Abura Dunkwa Chapter, thanked the FDA for the continuing education of herbal drug manufacturers and assured the FDA that the lessons learned would be put to good use.
The participants received certificates.